Radiation Therapy in the Oncology Market: Rising Demand for Stereotactic and Image-Guided Therapies

The increasing adoption of oncology treatment devices , image guided radiation therapy , and intensity modulated radiation therapy is revolutionizing cancer care by improving treatment precision, reducing side effects, and enhancing patient outcomes. Radiation therapy has become a crucial component of modern oncology, supporting the treatment of various cancers through targeted delivery of high-energy radiation to destroy malignant cells. With the rising global burden of cancer and growing demand for advanced treatment approaches, healthcare providers are investing in next-generation radiation technologies. The global radiation therapy in the oncology market was valued at USD 7.30 billion in 2024 and is projected to grow at a CAGR of 7.8% from 2025 to 2034. The market is expected to reach USD 7.85 billion in 2025 and further expand to USD 15.43 billion by 2034. Rising Demand for Advanced Oncology Treatment Devices Oncology treatment devices play a vital role in delivering accurate and effective cancer therapies. These devices are designed to improve radiation targeting, optimize treatment planning, and minimize exposure to surrounding healthy tissues. As cancer treatment continues moving toward personalized and precision medicine, advanced radiation systems are becoming increasingly important in hospitals, cancer centers, and specialty clinics. Modern oncology treatment devices include: Linear accelerators (LINACs) Radiation therapy planning systems Image-guided radiation systems Proton therapy systems Brachytherapy equipment Treatment monitoring and verification systems These technologies allow radiation oncologists to customize treatment plans based on tumor location, size, and patient-specific characteristics. The growing focus on reducing treatment complications while improving therapeutic effectiveness is accelerating the adoption of advanced oncology devices worldwide. Image Guided Radiation Therapy Improving Treatment Accuracy Image guided radiation therapy (IGRT) has emerged as one of the most important advancements in radiation oncology. IGRT combines advanced imaging technologies with radiation delivery systems, enabling physicians to visualize tumors and surrounding tissues during treatment sessions. Traditional radiation therapy relies on pre-treatment imaging, but tumors can shift due to patient movement, breathing patterns, or changes in anatomy. IGRT addresses these challenges by providing real-time imaging information, allowing clinicians to adjust radiation beams with greater accuracy. Key benefits of image guided radiation therapy include: Improved tumor targeting Reduced radiation exposure to healthy organs Better treatment precision Enhanced patient safety Increased effectiveness for complex tumors IGRT is widely used in treating cancers of the prostate, lung, brain, head and neck, and other sensitive anatomical regions where precise radiation delivery is essential. The growing adoption of IGRT is supported by increasing demand for minimally invasive cancer treatment options and advancements in imaging technologies. Intensity Modulated Radiation Therapy Advancing Precision Oncology Intensity modulated radiation therapy (IMRT) represents another major innovation within radiation oncology. IMRT uses computer-controlled linear accelerators to deliver radiation beams with varying intensities, allowing physicians to shape radiation doses according to the exact contours of tumors. Unlike conventional radiation techniques, IMRT enables higher radiation doses to be delivered directly to cancer cells while limiting damage to nearby healthy tissues. Advantages of intensity modulated radiation therapy include: Enhanced treatment accuracy Better protection of critical organs Improved tumor control Reduced treatment-related complications Personalized radiation dose distribution IMRT has become an important treatment approach for cancers located near sensitive structures, including head and neck tumors, prostate cancer,...